Personalized Consultation — $150 Deposit Applies to Your TreatmentReserve Your Spot →

GLP-1 & WEIGHT LOSS

Tirzepatide Results: What Studies Show

Dr. Alexander Landfield

Board-Certified Neurologist & Medical Director

January 10, 2026
GLP-1 & Weight Loss

Tirzepatide has generated enormous interest in the medical weight-management community, and the clinical data behind it is genuinely impressive. As a dual GIP and GLP-1 receptor agonist, tirzepatide works through two metabolic pathways simultaneously, and the results from landmark clinical trials reflect that dual mechanism. At Rani Beauty Clinic in Renton, WA, Dr. Alexander Landfield uses this data to set realistic expectations for every patient considering treatment.

The SURMOUNT-1 trial, the largest weight-loss study conducted for tirzepatide, enrolled over 2,500 adults with obesity or overweight with at least one weight-related comorbidity. At the highest dose, participants lost an average of 22.5 percent of their body weight over 72 weeks. Even at the lowest dose, average weight loss exceeded 15 percent. To put this in perspective, a patient weighing 250 pounds could expect to lose between 37 and 56 pounds depending on dosage and individual response. These numbers rival outcomes previously seen only with bariatric surgery.

Real-world results can differ from clinical trial data. Trial participants receive structured dietary counseling, exercise guidance, and regular monitoring that may not be replicated in every clinical setting. At Rani Beauty Clinic, we bridge that gap by providing the same level of comprehensive support. Every tirzepatide patient receives ongoing nutritional guidance, body-composition tracking, and regular lab work to monitor metabolic markers. Dr. Landfield adjusts dosing based on individual response, ensuring each patient gets the maximum benefit with the fewest side effects.

Beyond weight loss, tirzepatide has demonstrated meaningful improvements in cardiometabolic health markers. Clinical data shows reductions in blood pressure, triglycerides, and fasting insulin levels, along with improvements in HbA1c for patients with insulin resistance. These metabolic improvements mean that tirzepatide is not just helping patients lose weight but actively improving the health conditions that excess weight creates. Patients interested in tirzepatide at Rani Beauty Clinic begin with a thorough medical evaluation to determine candidacy and establish a personalized treatment plan.

FREQUENTLY ASKED QUESTIONS

Common Questions

Clinical trials showed average weight loss of 15 to 22.5 percent of body weight over 72 weeks depending on dosage. Individual results vary based on starting weight, adherence to lifestyle changes, and dosing. Dr. Landfield sets realistic goals during your consultation.

Most patients notice appetite reduction within the first one to two weeks. Meaningful weight loss typically becomes apparent by weeks four to six. Maximum results develop over 12 to 18 months of consistent treatment with lifestyle modifications.

Clinical trials suggest tirzepatide produces greater average weight loss than semaglutide, likely due to its dual-receptor mechanism. However, individual responses vary, and the best medication depends on your specific medical profile and how your body responds.

R
READY TO GET STARTED?

Book a Consultation

Take the next step toward your aesthetic and wellness goals with our expert, physician-supervised team.

Call NowBook Now